Cemiplimab (anti-PD-1)
Product Specifications
CAS Number
1801342-60-8
Synonyms
REGN-2810, cemiplimab-rwlc
Target
PD-1/PD-L1
Applications
Apoptosis
Additionnal Information
Cemiplimab (anti-PD-1) is an intravenous human monoclonal antibody directed against programmed cell death-1 receptor (PD-1) and blocks its interaction with programmed death ligands 1 (PD-L1) and 2 (PD-L2) . Cemiplimab blocks T-cell inactivation and enhances the immune system's anti-tumor response.
Storage Conditions
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RD-CbS-Mu-01 96 Tests
Mouse Cystathionine Beta Synthase (CbS) ELISA Kit
Sign In for Pricing
View Details RD-CbS-Mu-02 48 Tests
Mouse Cystathionine Beta Synthase (CbS) ELISA Kit
Sign In for Pricing
View Details 
OR1060044-01 100 mg
(S) -2- ((((9H-Fluoren-9-yl) methoxy) carbonyl) amino) -3- (1- ((allyloxy) carbonyl) piperidin-4-yl) propanoic acid
Sign In for Pricing
View Details